279 related articles for article (PubMed ID: 8998681)
1. A randomized controlled trial of salmon calcitonin to prevent bone loss in corticosteroid-treated temporal arteritis and polymyalgia rheumatica.
Healey JH; Paget SA; Williams-Russo P; Szatrowski TP; Schneider R; Spiera H; Mitnick H; Ales K; Schwartzberg P
Calcif Tissue Int; 1996 Feb; 58(2):73-80. PubMed ID: 8998681
[TBL] [Abstract][Full Text] [Related]
2. Salmon calcitonin nasal spray in the prevention of corticosteroid-induced osteoporosis.
Adachi JD; Bensen WG; Bell MJ; Bianchi FA; Cividino AA; Craig GL; Sturtridge WC; Sebaldt RJ; Steele M; Gordon M; Themeles E; Tugwell P; Roberts R; Gent M
Br J Rheumatol; 1997 Feb; 36(2):255-9. PubMed ID: 9133941
[TBL] [Abstract][Full Text] [Related]
3. Effect of intermittent administration of 200 IU intranasal salmon calcitonin and low doses of 1alpha(OH) vitamin D3 on bone mineral density of the lumbar spine and hip region and biochemical bone markers in women with postmenopausal osteoporosis: a pilot study.
Kaskani E; Lyritis GP; Kosmidis C; Galanos A; Andypas G; Chorianopoulos K; Giagiosis A; Iliadou K; Karagianis A; Katsimichas K; Koskinas A; Matsouka K
Clin Rheumatol; 2005 Jun; 24(3):232-8. PubMed ID: 15647969
[TBL] [Abstract][Full Text] [Related]
4. Glucocorticoids Are Not Associated with Bone Mineral Density in Patients with Polymyalgia Rheumatica, Giant Cell Arteritis and Other Vasculitides-Cross-Sectional Baseline Analysis of the Prospective Rh-GIOP Cohort.
Palmowski A; Wiebe E; Muche B; Hermann S; Dejaco C; Matteson EL; Buttgereit F
Cells; 2022 Feb; 11(3):. PubMed ID: 35159345
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of the efficacy of etidronate therapy in preventing glucocorticoid-induced bone loss in patients with inflammatory rheumatic diseases. A randomized study.
Cortet B; Hachulla E; Barton I; Bonvoisin B; Roux C
Rev Rhum Engl Ed; 1999 Apr; 66(4):214-9. PubMed ID: 10339777
[TBL] [Abstract][Full Text] [Related]
6. Prevention of corticosteroid osteoporosis. A comparison of calcium, calcitriol, and calcitonin.
Sambrook P; Birmingham J; Kelly P; Kempler S; Nguyen T; Pocock N; Eisman J
N Engl J Med; 1993 Jun; 328(24):1747-52. PubMed ID: 7684512
[TBL] [Abstract][Full Text] [Related]
7. Prevention of bone loss and vertebral fractures in patients with chronic epilepsy--antiepileptic drug and osteoporosis prevention trial.
Lazzari AA; Dussault PM; Thakore-James M; Gagnon D; Baker E; Davis SA; Houranieh AM
Epilepsia; 2013 Nov; 54(11):1997-2004. PubMed ID: 24010637
[TBL] [Abstract][Full Text] [Related]
8. Prevention of corticosteroid bone loss.
Sambrook P; Birmingham J; Kelly P; Kempler S; Nguyen T; Pocock N; Eisman J
Osteoporos Int; 1993; 3 Suppl 1():141-3. PubMed ID: 8461542
[TBL] [Abstract][Full Text] [Related]
9. Effect of long-term calcitonin administration on steroid-induced osteoporosis after cardiac transplantation.
Kapetanakis EI; Antonopoulos AS; Antoniou TA; Theodoraki KA; Zarkalis DA; Sfirakis PD; Chilidou DA; Alivizatos PA
J Heart Lung Transplant; 2005 May; 24(5):526-32. PubMed ID: 15896748
[TBL] [Abstract][Full Text] [Related]
10. Effects of 4-year treatment with once-weekly clodronate on prevention of corticosteroid-induced bone loss and fractures in patients with arthritis: evaluation with dual-energy X-ray absorptiometry and quantitative ultrasound.
Frediani B; Falsetti P; Baldi F; Acciai C; Filippou G; Marcolongo R
Bone; 2003 Oct; 33(4):575-81. PubMed ID: 14555261
[TBL] [Abstract][Full Text] [Related]
11. A randomized, placebo-controlled trial of calcium supplementation for decreased bone density in corticosteroid-using patients with inflammatory bowel disease: a pilot study.
Bernstein CN; Seeger LL; Anton PA; Artinian L; Geffrey S; Goodman W; Belin TR; Shanahan F
Aliment Pharmacol Ther; 1996 Oct; 10(5):777-86. PubMed ID: 8899087
[TBL] [Abstract][Full Text] [Related]
12. A randomized trial of nasal spray salmon calcitonin in postmenopausal women with established osteoporosis: the prevent recurrence of osteoporotic fractures study. PROOF Study Group.
Chesnut CH; Silverman S; Andriano K; Genant H; Gimona A; Harris S; Kiel D; LeBoff M; Maricic M; Miller P; Moniz C; Peacock M; Richardson P; Watts N; Baylink D
Am J Med; 2000 Sep; 109(4):267-76. PubMed ID: 10996576
[TBL] [Abstract][Full Text] [Related]
13. Calcitonin therapy in osteoporosis.
Muñoz-Torres M; Alonso G; Raya MP
Treat Endocrinol; 2004; 3(2):117-32. PubMed ID: 15743107
[TBL] [Abstract][Full Text] [Related]
14. Effects of salmon calcitonin on trabecular microarchitecture as determined by magnetic resonance imaging: results from the QUEST study.
Chesnut CH; Majumdar S; Newitt DC; Shields A; Van Pelt J; Laschansky E; Azria M; Kriegman A; Olson M; Eriksen EF; Mindeholm L
J Bone Miner Res; 2005 Sep; 20(9):1548-61. PubMed ID: 16059627
[TBL] [Abstract][Full Text] [Related]
15. The deleterious effects of low-dose corticosteroids on bone density in patients with polymyalgia rheumatica.
Pearce G; Ryan PF; Delmas PD; Tabensky DA; Seeman E
Br J Rheumatol; 1998 Mar; 37(3):292-9. PubMed ID: 9566670
[TBL] [Abstract][Full Text] [Related]
16. A randomized, double-blind, multicenter, placebo-controlled study to evaluate the efficacy and safety of oral salmon calcitonin in the treatment of osteoporosis in postmenopausal women taking calcium and vitamin D.
Henriksen K; Byrjalsen I; Andersen JR; Bihlet AR; Russo LA; Alexandersen P; Valter I; Qvist P; Lau E; Riis BJ; Christiansen C; Karsdal MA;
Bone; 2016 Oct; 91():122-9. PubMed ID: 27462009
[TBL] [Abstract][Full Text] [Related]
17. Positive effect of alendronate on bone mineral density and markers of bone turnover in patients with rheumatoid arthritis on chronic treatment with low-dose prednisone: a randomized, double-blind, placebo-controlled trial.
Lems WF; Lodder MC; Lips P; Bijlsma JW; Geusens P; Schrameijer N; van de Ven CM; Dijkmans BA
Osteoporos Int; 2006; 17(5):716-23. PubMed ID: 16463007
[TBL] [Abstract][Full Text] [Related]
18. Vitamin D and calcium in the prevention of corticosteroid induced osteoporosis: a 3 year followup.
Adachi JD; Bensen WG; Bianchi F; Cividino A; Pillersdorf S; Sebaldt RJ; Tugwell P; Gordon M; Steele M; Webber C; Goldsmith CH
J Rheumatol; 1996 Jun; 23(6):995-1000. PubMed ID: 8782129
[TBL] [Abstract][Full Text] [Related]
19. Nasal salmon calcitonin blunts bone microstructure alterations in healthy postmenopausal women.
Rizzoli R; Sigaud A; Azria M; Herrmann FR
Osteoporos Int; 2015 Jan; 26(1):383-93. PubMed ID: 25566730
[TBL] [Abstract][Full Text] [Related]
20. Prevention of further bone mass loss by nasal calcitonin in patients on long term glucocorticoid therapy for asthma: a two year follow up study.
Luengo M; Pons F; Martinez de Osaba MJ; Picado C
Thorax; 1994 Nov; 49(11):1099-102. PubMed ID: 7831624
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
